NASDAQ: TTNPTitan Pharmaceuticals Inc Stock Ownership - Who owns Titan Pharmaceuticals?
Insider buying vs selling
Have Titan Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David E. Lazar | Chief Executive Officer | 2023-06-21 | 359,066 | $1.23 | $441.65kSell |
| David E. Lazar | Chief Executive Officer | 2023-06-21 | 3,388,902 | $1.23 | $4.17MSell |
| David E. Lazar | Chief Executive Officer | 2023-06-21 | 359,066 | $1.23 | $441.65kSell |
| David E. Lazar | Chief Executive Officer | 2023-06-21 | 3,388,902 | $1.23 | $4.17MSell |
| David E. Lazar | Chief Executive Officer | 2023-06-21 | 359,066 | $1.23 | $441.65kSell |
| David E. Lazar | Chief Executive Officer | 2023-06-21 | 3,388,902 | $1.23 | $4.17MSell |
TTNP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TTNP insiders and whales buy or sell their stock.
TTNP Shareholders
What type of owners hold Titan Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sire Group Ltd | 2,279.10% | 20,836,266 | $147.73M | Insider |
| Pharmaceuticals Bvba Sprl Braeburn | 1,055.53% | 9,650,000 | $68.42M | Insider |
| Choon Hau Choong | 415.88% | 3,802,100 | $26.96M | Insider |
| Federico Seghi Recli | 87.60% | 800,845 | $5.68M | Insider |
| Truist Financial Corp | 68.37% | 625,089 | $4.43M | Institution |
| Sunil Bhonsle | 66.95% | 612,050 | $4.34M | Insider |
| Marc Rubin | 60.85% | 556,317 | $3.94M | Insider |
| Louis R. Md Bucalo | 60.16% | 550,000 | $3.90M | Insider |
| Joachim Friedrich Kapp | 59.76% | 546,339 | $3.87M | Insider |
| Robert Edward Farrell | 35.07% | 320,580 | $2.27M | Insider |
TTNP vs Biotech Stocks
Titan Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.